Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia

被引：0

作者：

Mark Bounthavong

Javed Butler

Chantal M. Dolan

Jeffrey D. Dunn

Kathryn A. Fisher

Nina Oestreicher

Bertram Pitt

Paul J. Hauptman

David L. Veenstra

机构：

[1] University of Washington,Department of Pharmacy

[2] Stony Brook University,Division of Cardiology

[3] CMD Consulting,Epidemiology, HEOR and Observational Research

[4] Magellan Rx,Department of Clinical Pharmacy

[5] Relypsa,Division of Cardiology, Department of Medicine

[6] Inc.,undefined

[7] a Vifor Pharma Group Company,undefined

[8] University of California,undefined

[9] University of Michigan School of Medicine,undefined

[10] Saint Louis University School of Medicine,undefined

来源：

PharmacoEconomics | 2019年 / 37卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Correction to Bounthavong M, Butler J, Dolan CM, Dunn JD, Fisher KA, Oestreicher N, Pitt B, Hauptman PJ, Veenstra DL.

引用

页码：1071 / 1071